• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单侧伊尔斯病:一例报告。

Unilateral Eales' disease a case report.

作者信息

Nicolcescu Andreea, Mocanu Carmen, Dinu Loredana, Olaru Andrei, Ionete Mara, Stefanescu Dima Alin

机构信息

Department of Ophthalmology, Clinical Emergency Hospital, Craiova, Romania.

Department of Ophthalmology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

出版信息

Rom J Ophthalmol. 2017 Apr-Jun;61(2):144-149. doi: 10.22336/rjo.2017.27.

DOI:10.22336/rjo.2017.27
PMID:29450389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5710024/
Abstract

Eales disease is an idiopathic peripheral vascular occlusive disease characterized by inflammation, ischemia, and retinal neovascularization and is hallmarked by recurrent vitreous hemorrhages and vision loss. We present a case of a 48-year-old female with recurrent floaters and decreased vision in her right eye. The onset of symptoms was in 2007 when a diagnose of retinal vasculitis was made. She had no accompanying systemic signs and symptoms and no history of ocular trauma or previous tuberculosis infection. The eye condition was managed only with intermittent focal laser treatment, because the general treatment with steroids was not efficient and poorly tolerated. After the laser treatment, the visual acuity completely recovered and there was no recurrence of vitreous hemorrhage. The case particularity was the unilaterality after 9 years from the onset.

摘要

伊尔斯病是一种特发性外周血管闭塞性疾病,其特征为炎症、缺血和视网膜新生性视网膜新生血管形成,以反复玻璃体出血和视力丧失为特点。我们报告一例48岁女性患者,其右眼反复出现飞蚊症且视力下降。症状于2007年开始出现,当时被诊断为视网膜血管炎。她没有伴随的全身症状,也没有眼部外伤史或既往结核感染史。由于使用类固醇进行全身治疗无效且耐受性差,眼部疾病仅采用间歇性局部激光治疗。激光治疗后,视力完全恢复,且未再发生玻璃体出血。该病例的特殊性在于发病9年后仍为单侧性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/da68a4d757a1/RomJOphthalmol-61-144-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/86d8ddadfcfe/RomJOphthalmol-61-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/3ec12b9cebfc/RomJOphthalmol-61-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/ebe888cb2732/RomJOphthalmol-61-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/82f641f57982/RomJOphthalmol-61-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/740bbf120db8/RomJOphthalmol-61-144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/da68a4d757a1/RomJOphthalmol-61-144-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/86d8ddadfcfe/RomJOphthalmol-61-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/3ec12b9cebfc/RomJOphthalmol-61-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/ebe888cb2732/RomJOphthalmol-61-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/82f641f57982/RomJOphthalmol-61-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/740bbf120db8/RomJOphthalmol-61-144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eabf/5710024/da68a4d757a1/RomJOphthalmol-61-144-g006.jpg

相似文献

1
Unilateral Eales' disease a case report.单侧伊尔斯病:一例报告。
Rom J Ophthalmol. 2017 Apr-Jun;61(2):144-149. doi: 10.22336/rjo.2017.27.
2
Progression of Eales' disease post-partum and long-term follow-up: a case report.产后伊尔斯病的进展及长期随访:一例报告
J Med Case Rep. 2018 Oct 17;12(1):310. doi: 10.1186/s13256-018-1768-y.
3
Central retinal artery occlusion as a presenting symptom in Eales' disease: a case report.视网膜中央动脉阻塞作为 Eales 病的首发症状:一例报告。
J Med Case Rep. 2023 Jul 6;17(1):309. doi: 10.1186/s13256-023-04003-y.
4
A rare presentation of exudative macroaneurysms in unilateral Eales' disease.单侧伊尔斯病中渗出性大动脉瘤的罕见表现。
Nepal J Ophthalmol. 2017 Jan;9(18):95-98. doi: 10.3126/nepjoph.v9i1.17544.
5
Eales' disease: diagnosis and management.Eales 病:诊断与管理。
Eye (Lond). 2010 Mar;24(3):472-82. doi: 10.1038/eye.2009.315. Epub 2010 Jan 15.
6
Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.初诊时伴有新生血管性青光眼的晚期伊尔斯病
Cureus. 2021 Sep 26;13(9):e18302. doi: 10.7759/cureus.18302. eCollection 2021 Sep.
7
[Surgical treatment of recurrent retinovitreous hemorrhage in young subjects (Eales' disease)].
Ophthalmologica. 1954 Apr-May;127(4-5):339-41. doi: 10.1159/000301983.
8
Eales' disease: the great masquerader.伊尔斯病:极具伪装性的疾病。
Optometry. 2009 Jul;80(7):354-9. doi: 10.1016/j.optm.2008.10.016.
9
[Eales' disease].[伊尔斯病]
J Fr Ophtalmol. 2016 May;39(5):474-82. doi: 10.1016/j.jfo.2016.03.001. Epub 2016 May 13.
10
A long-term follow-up of Eales' disease.伊尔斯病的长期随访
Ocul Immunol Inflamm. 2002 Sep;10(3):213-21. doi: 10.1076/ocii.10.3.213.15598.

引用本文的文献

1
A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature.伊尔斯病管理的多学科方法:病例报告及文献综述
J Pers Med. 2024 Feb 22;14(3):235. doi: 10.3390/jpm14030235.
2
Central retinal artery occlusion as a presenting symptom in Eales' disease: a case report.视网膜中央动脉阻塞作为 Eales 病的首发症状:一例报告。
J Med Case Rep. 2023 Jul 6;17(1):309. doi: 10.1186/s13256-023-04003-y.
3
Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.初诊时伴有新生血管性青光眼的晚期伊尔斯病

本文引用的文献

1
The use of a vascular endothelial growth factor inhibitor (ranibizumab) in macular edema due to eales disease.血管内皮生长因子抑制剂(雷珠单抗)在伊尔斯病所致黄斑水肿中的应用。
Retin Cases Brief Rep. 2012 Winter;6(1):122-4. doi: 10.1097/ICB.0b013e31821608e8.
2
Association of mycobacteria with Eales' disease.分枝杆菌与伊尔斯病的关联。
Indian J Med Res. 2007 Jul;126(1):56-62.
3
Intravitreal triamcinolone acetonide in Eales disease.玻璃体内注射曲安奈德治疗伊尔斯病
Cureus. 2021 Sep 26;13(9):e18302. doi: 10.7759/cureus.18302. eCollection 2021 Sep.
4
Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.玻璃体内注射布罗珠单抗后发生的视网膜动脉闭塞性血管炎。
Am J Ophthalmol Case Rep. 2020 Mar 31;18:100680. doi: 10.1016/j.ajoc.2020.100680. eCollection 2020 Jun.
Retina. 2006 Feb;26(2):227-9. doi: 10.1097/00006982-200602000-00020.